Impact of sacubitril/valsartan on implantable defibrillator eligibility in heart failure: a real-world experience

被引：0
|
作者：
Monzo, L. [1 ]
Cicogna, F. [2 ]
Tota, C. [2 ]
Petronilli, V. [2 ]
Mennuni, S. [2 ]
De Ruvo, E. [2 ]
Calo, L. [2 ]
机构：
[1] Sapienza Univ Rome, Dept Clin Internal Anesthesiol & Cardiovasc Sci, Rome, Italy
[2] Polyclin Casilino Rome, Dept Cardiol, Rome, Italy
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2021年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：42 / 43
页数：2
相关论文
共 50 条
  • [31] THE USE OF SACUBITRIL/VALSARTAN: A REAL WORLD EXPERIENCE IN A HIGH VOLUME SPECIALIST HEART FAILURE SERVICE
    Murray, G.
    Barrett, M.
    Earls, S.
    Hammond, M.
    Campbell, P.
    O'Hanlon, R.
    McDonald, K.
    HEART, 2017, 103 : A8 - A9
  • [32] Sacubitril/valsartan in chronic symptomatic heart failure: a real world experience of delivery and outcomes.
    Kearney, A. Aileen
    Hill, L.
    Davidson, J.
    Mc Clure, C.
    Dixon, L.
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 411 - 411
  • [33] Sacubitril-Valsartan: real-world single-centre experience
    Climent, Herminio Morillas
    Lopez, Alvaro Vicedo
    Moya, Julia Seller
    Torres, Edgard Alania
    Jornet, Emilio Galcera
    Rodriguez, Ainhoa Larumbe
    Piles, Carlos Nunez
    Munoz, Alfonso Valle
    EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 : 257 - 257
  • [34] Utilization of sacubitril/valsartan in real-world settings
    Eworuke, Efe
    Menzin, Talia
    Kolonoski, Joy
    Huang, Ting-Ying
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 144 - 145
  • [35] Utilization of Sacubitril/Valsartan in Real-World Settings
    Eworuke, Efe
    Menzin, Talia J.
    Welch, Emily C.
    Kolonoski, Joy
    Huang, Ting-Ying
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2020, 20 (06) : 619 - 623
  • [36] Prescription of sacubitril/valsartan in a real-world population
    Joao Pedro Ribeiro Agostinho, J. R.
    Rodrigues, T.
    Santos, R.
    Cunha, N.
    Rigueira, J.
    Nunes-Ferreira, A.
    Aguiar-Ricardo, I.
    Goncalves, I.
    Guimaraes, T.
    Longo, S.
    Veiga, F.
    Ribeiro, M.
    Lousada, N.
    Pinto, F. J.
    Brito, D.
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 228 - 228
  • [37] Utilization of Sacubitril/Valsartan in Real-World Settings
    Efe Eworuke
    Talia J. Menzin
    Emily C. Welch
    Joy Kolonoski
    Ting-Ying Huang
    American Journal of Cardiovascular Drugs, 2020, 20 : 619 - 623
  • [38] PHARMACOUTILIZATION AND ADHERENCE TO SACUBITRIL/VALSARTAN IN REAL-WORLD: THE REAL.IT STUDY IN HEART FAILURE WITH REDUCED EJECTION FRACTION
    Iacoviello, M.
    Di Gesaro, G.
    Sarullo, F.
    Miani, D.
    Driussi, M.
    Correale, M.
    Bilato, C.
    Passantino, A.
    Carluccio, E.
    Villani, A.
    Esposti, L. Degli
    D'Agostino, C.
    Peruzzi, E.
    Poli, S.
    Di Lenarda, A.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2023, 25
  • [39] Eligibility for sacubitril/valsartan in heart failure across the ejection fraction spectrum: real-world data from the Swedish Heart Failure Registry (vol 289, pg 369, 2021)
    Savarese, G.
    Hage, C.
    Benson, L.
    Schrage, B.
    Thorvaldsen, T.
    Lundberg, A.
    Fudim, M.
    Linde, C.
    Dahlstrom, U.
    Rosano, G. M. C.
    JOURNAL OF INTERNAL MEDICINE, 2021, 290 (01) : 238 - 238
  • [40] Effects of sacubitril/valsartan on real-world patients with heart failure due to non-ischemic cardiomyopathy
    Hsu, C-Y
    Lin, Y-C
    Huang, C-Y
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 407 - 408
12345